Oncogenic Viruses - Tiny Tumour Triggers
- Definition: Viruses causing cancer by disrupting host cell cycle control and growth regulation.
- Classification:
- DNA Viruses: e.g., HPV, EBV, HBV, HHV-8, MCPyV.
- RNA Viruses: e.g., HTLV-1, HCV.
- General Mechanisms:
- Direct: Viral oncogenes (v-onc) integrate or persist episomally. Key actions: activate proto-oncogenes, inactivate tumour suppressor genes (TSGs) like p53, Rb. Results in cell transformation, immortalization.
- Indirect: Chronic inflammation (e.g., HBV, HCV leading to hepatocellular carcinoma) or immunosuppression.
- Key Terms: Proto-oncogenes, TSGs (p53, Rb), transformation, immortalization, latency (viral persistence).
⭐ HPV E6 oncoprotein targets p53 for ubiquitin-mediated degradation; E7 oncoprotein binds and inactivates Rb.
DNA Oncogenic Viruses - Genome Invaders
These viruses integrate their genetic material or viral proteins to disrupt host cell cycle regulation, leading to uncontrolled proliferation.
- Key Mechanisms:
- Inactivation of tumor suppressor proteins (p53, Rb)
- Activation of proto-oncogenes
- Chronic inflammation leading to cell damage and regeneration
| Virus | Family | Key Proteins/Genes | Target Pathways/Mechanism | Associated Cancers |
|---|---|---|---|---|
| HPV | Papillomaviridae | E6, E7 | E6 → p53 degradation; E7 → Rb inactivation | Cervical, anogenital, oropharyngeal carcinomas 📌 16, 18 >70% cervical Ca |
| EBV | Herpesviridae | LMP1, EBNA2 | LMP1 (CD40 mimic), EBNA2 (gene activation) | Burkitt's & Hodgkin's lymphoma, Nasopharyngeal Ca, Gastric Ca |
| HBV | Hepadnaviridae | HBx | HBx → cell cycle disruption, p53 inactivation (indirect) | Hepatocellular carcinoma (HCC) |
| HHV-8 (KSHV) | Herpesviridae | LANA, v-cyclin, v-FLIP | Proliferation ↑, Apoptosis ↓ | Kaposi's sarcoma, Primary effusion lymphoma |
| MCV | Polyomaviridae | LT & sT antigens | LT → p53 & Rb inactivation | Merkel cell carcinoma |
RNA Oncogenic Viruses - Reverse Rebels
RNA viruses with oncogenic potential, primarily HTLV-1 (a retrovirus) and HCV (a Flavivirus). They employ distinct mechanisms for carcinogenesis.
- Human T-cell Lymphotropic Virus 1 (HTLV-1)
- Retrovirus; integrates into host genome.
- Key protein: Tax (transcriptional activator/co-activator).
- Mechanism: Tax transactivates cellular genes (e.g., IL-2, IL-2R), promotes cell proliferation, induces genomic instability, inhibits apoptosis.
- Cancer: Adult T-cell Leukemia/Lymphoma (ATLL).
- Hepatitis C Virus (HCV)
- Flavivirus; RNA virus, does not integrate into host DNA.
- Key proteins: Core, NS3, NS5A.
- Mechanism: Chronic inflammation & regeneration → cirrhosis; oxidative stress → DNA damage; viral proteins directly alter cell signaling pathways (e.g., interfere with p53).
- Cancer: Hepatocellular Carcinoma (HCC).
| Virus | Family | Key Proteins | Mechanism | Associated Cancers |
|---|---|---|---|---|
| HTLV-1 | Retroviridae | Tax | Transactivation of cellular genes, genomic instability, anti-apoptosis | ATLL |
| HCV | Flaviviridae | Core, NS3, NS5A | Chronic inflammation, oxidative stress, direct protein effects on signaling | HCC |
📌 RNA Rebels: HTLV-1 Tax Activates T-cells; HCV Causes Hepatocellular Carcinoma via Chronic inflammation.
High‑Yield Points - ⚡ Biggest Takeaways
- HPV types 16, 18 are key for cervical cancer; E6 targets p53, E7 targets Rb.
- EBV is associated with Burkitt's lymphoma, nasopharyngeal carcinoma, and Hodgkin's lymphoma.
- HBV & HCV significantly increase risk for hepatocellular carcinoma (HCC).
- HTLV-1 is the causative agent for Adult T-cell Leukemia/Lymphoma (ATLL).
- KSHV/HHV-8 causes Kaposi's sarcoma and primary effusion lymphoma.
- Key mechanisms: inactivating tumor suppressors (p53, Rb), activating oncogenes, viral integration, chronic inflammation.
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more
